A TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT SYSTEM IS USED TO TREAT VARIOUS MITRAL VALVE DISORDERS (MITRAL VALVE STENOSIS, MITRAL VALVE PROLAPSE, MITRAL VALVE REGURGITATION) USING MINIMALLY INVASIVE TRANSCATHETER PROCEDURES. THESE LESS INVASIVE PROCEDURES ARE SUITABLE THERAPEUTIC ALTERNATIVES FOR THOSE PEOPLE WHO CANNOT UNDERGO OPEN-HEART SURGERY DUE TO HEALTH CONCERNS.

THE RISING WORLDWIDE DEMAND FOR TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT SYSTEMS IS BECAUSE OF THE INCREASING TECHNOLOGICAL ADVANCEMENTS IN SURGICAL PROCEDURES AND UPSURGE IN VENTURE CAPITAL INVESTMENTS. FOR INSTANCE, THE MEDICAL TECHNOLOGY VENTURE CAPITAL INVESTMENT ALL OVER THE WORLD WAS VALUED AT 5.7 BILLION U.S. DOLLARS IN 2019 WHICH ROSE TO 6.3 BILLION U.S. DOLLARS IN 2020. IN ADDITION TO THIS, THE LARGEST INCREASE IN THE MEDTECH VENTURE CAPITAL INVESTMENT WAS SEEN DURING THE YEARS 2016 AND 2017.

THE GROWING PREVALENCE OF HEART VALVE DISEASE COUPLED WITH THE RISING GERIATRIC POPULATION IS ANOTHER FACTOR CONTRIBUTING TO THE GROWTH OF THE GLOBAL TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT SYSTEMS MARKET. FOR INSTANCE, ACCORDING TO THE UNITED NATIONS, IN 2019, 13.2% OF THE WORLDWIDE POPULATION WAS AGED 60 YEARS OR ABOVE. FURTHER, IT IS ANTICIPATED THAT NEARLY 21.4% OF THE TOTAL WORLDWIDE POPULATION WILL BE AGED 60 YEARS OR OVER BY 2050. IN VIEW OF THESE FACTS, THERE IS AN INCREASE IN THE NUMBER OF PEOPLE WHO ARE NOT SUITABLE FOR OPEN-HEART SURGERIES. AS A RESULT, THERE IS AN INCREASE IN THE ADOPTION OF MINIMALLY INVASIVE SURGICAL PROCEDURES SUCH AS TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT PROCEDURES AUGMENTING THE GROWTH OF TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET GLOBALLY.

HOWEVER, SOME OF THE RESTRAINTS IN THE MARKET INCLUDE STRINGENT GOVERNMENT REGULATIONS, HIGH COST AND RISK ASSOCIATED WITH THE TRANSCATHETER MITRAL VALVE REPLACEMENT PROCEDURES ARE IMPEDING THE GROWTH OF THIS MARKET ALL OVER THE WORLD.

BASED ON PRODUCTS, THE MARKET IS DIVIDED INTO MECHANICAL VALVES AND BIOPROSTHETIC VALVES. THE MECHANICAL VALVES SEGMENT GENERATED REVENUE OF USD XX MILLION IN 2020. THE SEGMENT IS EXPECTED TO GROW AT A CAGR OF XX% DURING THE FORECAST PERIOD TO REACH A MARKET VALUATION OF USD XX MILLION BY 2027 OWING TO THE SEVERAL ADVANTAGES OFFERED BY THESE VALVES OVER BIOPROSTHETIC VALVES.

BASED ON INDICATION, THE MARKET IS SEGMENTED INTO MITRAL VALVE STENOSIS, MITRAL VALVE PROLAPSE, AND MITRAL VALVE REGURGITATION. THE MITRAL VALVE STENOSIS SEGMENT GRABBED XX% MARKET SHARE OF THE GLOBAL TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET AND GATHERED REVENUE OF USD XX MILLION IN 2020. THE SEGMENT IS EXPECTED TO GROW AT A CAGR OF XX% DURING THE FORECAST PERIOD TO REACH A MARKET VALUATION OF USD XX MILLION BY 2027. HOWEVER, THE MITRAL VALVE REGURGITATION SEGMENT IS EXPECTED TO WITNESS A CAGR OF XX% DURING THE FORTHCOMING YEARS.

FOR A BETTER UNDERSTANDING OF THE MARKET ADOPTION OF TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT PROCEDURES, THE MARKET IS ANALYZED BASED ON ITS WORLDWIDE PRESENCE IN THE COUNTRIES SUCH AS NORTH AMERICA (UNITED STATES, CANADA, AND THE REST OF NORTH AMERICA), EUROPE (GERMANY, FRANCE, ITALY, SPAIN, UNITED KINGDOM AND REST OF EUROPE), ASIA-PACIFIC (CHINA, JAPAN, INDIA, AUSTRALIA AND REST OF APAC), AND REST OF WORLD. NORTH AMERICA CONSTITUTES THE LARGEST MARKET FOR THE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT INDUSTRY AND GENERATED REVENUE OF USD XX MILLION IN 2020 OWING TO THE GOVERNMENT SUPPORT FOR ADVANCED RESEARCH AND DEVELOPMENT IN THE FIELD OF LESS INVASIVE MITRAL VALVE REPAIR AND REPLACEMENT PROCEDURES AND INCREASING AWARENESS REGARDING THE BENEFITS OFFERED BY THEM.

SOME OF THE MAJOR PLAYERS OPERATING IN THE MARKET INCLUDE MEDTRONIC PLC, ABBOTT LABORATORIES, EDWARDS LIFESCIENCES CORPORATION, COLIBRI HEART VALVE, LIVANOVA PLC, BOSTON SCIENTIFIC CORPORATION, HIGHLIFE MEDICAL, NEOVASC INC., MICRO INTERVENTIONAL DEVICES, JENAVALVE TECHNOLOGY. SEVERAL M&A'S ALONG WITH PARTNERSHIPS HAVE BEEN UNDERTAKEN BY THESE PLAYERS TO BOOST THEIR PRESENCE IN DIFFERENT REGIONS.